The family of a 17-year-old Texas cheerleader filed a wrongful death lawsuit, claiming she died from an enlarged heart after consuming energy drinks.
An Indiana couple faces murder and neglect charges after their malnourished toddler died from eating non-food items to survive in squalid conditions.
About 34,000 doormen, concierges and building workers in New York City are threatening to strike over wage and health insurance disputes.
New food standards for English schools will prohibit deep-fried items like fish and chips and chicken nuggets as part of childhood obesity prevention efforts.
A 16-year-old boy died after being stabbed near a shopping centre in Peterborough, with four teenagers arrested in connection with the incident.
NHS managers urge patients to continue seeking medical care as junior doctors begin strike action following the bank holiday weekend.
Catholic nuns challenge New York law requiring nursing homes to follow gender identity rules, claiming religious freedom conflict.
The FDA granted expedited approval to Eli Lilly's Foundayo, a daily weight-loss pill that joins Novo Nordisk's oral Wegovy in the growing obesity drug market.
Robert F. Kennedy Jr. has changed the membership requirements for a key CDC vaccine advisory committee following a recent court decision.
Research involving over 9,000 adults found higher levels of optimism may be associated with reduced risk of developing dementia over time.
A lawsuit challenges Georgia's laws that criminalize certain midwifery practices as maternal health outcomes worsen in the state.
Recent research explores connections between sleep patterns and heart health, student athletics and school attendance, and personality traits linked to dementia risk.
New school meal guidelines ban deep-fried foods and emphasize vegetables, while McDonald's adds energy drinks to its U.S. menu offerings.
Research suggests users of weight-loss drugs including Ozempic may face doubled divorce rates, similar to patterns seen in bariatric surgery patients.
Gilead Sciences announced plans to acquire German cancer drug developer Tubulis for up to $5 billion to strengthen its oncology pipeline.
Page 3 of 17 (245 stories)